Cargando…
Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly
DNA vaccination has tremendous potential for treating or preventing numerous diseases for which traditional vaccines are ineffective but the technique can be limited by low immunogenicity. Current synthetic DNA delivery systems are versatile and safe, but substantially less efficient than viruses. H...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124441/ https://www.ncbi.nlm.nih.gov/pubmed/17686512 http://dx.doi.org/10.1016/j.biomaterials.2007.07.002 |
_version_ | 1783515831530946560 |
---|---|
author | Zhou, Xianfeng Liu, Bin Yu, Xianghui Zha, Xiao Zhang, Xizhen Wang, Xueyun Chen, Yu Chen, Yan Chen, Yue Shan, Yaming Jin, Yinghua Wu, Yongge Liu, Junqiu Kong, Wei Shen, Jiacong |
author_facet | Zhou, Xianfeng Liu, Bin Yu, Xianghui Zha, Xiao Zhang, Xizhen Wang, Xueyun Chen, Yu Chen, Yan Chen, Yue Shan, Yaming Jin, Yinghua Wu, Yongge Liu, Junqiu Kong, Wei Shen, Jiacong |
author_sort | Zhou, Xianfeng |
collection | PubMed |
description | DNA vaccination has tremendous potential for treating or preventing numerous diseases for which traditional vaccines are ineffective but the technique can be limited by low immunogenicity. Current synthetic DNA delivery systems are versatile and safe, but substantially less efficient than viruses. Here, a novel multicomponent supramolecular system involving the preparation of mannose-bearing chitosan oligomers microspheres with entrapping complexes of DNA vaccine and polyethylenimine was developed to mimic many of the beneficial properties of the viruses. After delivery by intramuscular immunization in BALB/c mice, the microspheres induced an enhanced serum antibody responses two orders of magnitude greater than naked DNA vaccine. Additionally, in contrast to naked DNA, the microspheres induced potent cytotoxic T lymphocyte responses at a low dose. Consequently, formulation of DNA vaccines into multicomponent vectors is a powerful means of increasing vaccine potency. |
format | Online Article Text |
id | pubmed-7124441 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71244412020-04-08 Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly Zhou, Xianfeng Liu, Bin Yu, Xianghui Zha, Xiao Zhang, Xizhen Wang, Xueyun Chen, Yu Chen, Yan Chen, Yue Shan, Yaming Jin, Yinghua Wu, Yongge Liu, Junqiu Kong, Wei Shen, Jiacong Biomaterials Article DNA vaccination has tremendous potential for treating or preventing numerous diseases for which traditional vaccines are ineffective but the technique can be limited by low immunogenicity. Current synthetic DNA delivery systems are versatile and safe, but substantially less efficient than viruses. Here, a novel multicomponent supramolecular system involving the preparation of mannose-bearing chitosan oligomers microspheres with entrapping complexes of DNA vaccine and polyethylenimine was developed to mimic many of the beneficial properties of the viruses. After delivery by intramuscular immunization in BALB/c mice, the microspheres induced an enhanced serum antibody responses two orders of magnitude greater than naked DNA vaccine. Additionally, in contrast to naked DNA, the microspheres induced potent cytotoxic T lymphocyte responses at a low dose. Consequently, formulation of DNA vaccines into multicomponent vectors is a powerful means of increasing vaccine potency. Elsevier Ltd. 2007-11 2007-08-07 /pmc/articles/PMC7124441/ /pubmed/17686512 http://dx.doi.org/10.1016/j.biomaterials.2007.07.002 Text en Copyright © 2007 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Zhou, Xianfeng Liu, Bin Yu, Xianghui Zha, Xiao Zhang, Xizhen Wang, Xueyun Chen, Yu Chen, Yan Chen, Yue Shan, Yaming Jin, Yinghua Wu, Yongge Liu, Junqiu Kong, Wei Shen, Jiacong Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly |
title | Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly |
title_full | Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly |
title_fullStr | Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly |
title_full_unstemmed | Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly |
title_short | Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly |
title_sort | enhance immune response to dna vaccine based on a novel multicomponent supramolecular assembly |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124441/ https://www.ncbi.nlm.nih.gov/pubmed/17686512 http://dx.doi.org/10.1016/j.biomaterials.2007.07.002 |
work_keys_str_mv | AT zhouxianfeng enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly AT liubin enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly AT yuxianghui enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly AT zhaxiao enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly AT zhangxizhen enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly AT wangxueyun enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly AT chenyu enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly AT chenyan enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly AT chenyue enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly AT shanyaming enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly AT jinyinghua enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly AT wuyongge enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly AT liujunqiu enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly AT kongwei enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly AT shenjiacong enhanceimmuneresponsetodnavaccinebasedonanovelmulticomponentsupramolecularassembly |